Covered recipient · General Payments record
ARASH ZARRIN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2022–2024
$840.61
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $326.92 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $72.83 | 3 |
| Medtronic, Inc. | $37.94 | 1 |
| Janssen Biotech, Inc. | $34.99 | 1 |
| Ardelyx, Inc. | $26.94 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $23.92 | 1 |
| QOL Medical, LLC | $23.80 | 1 |
| Celgene Corporation | $21.80 | 1 |
| Merck Sharp & Dohme Corporation | $20.19 | 1 |
| Madrigal Pharmaceuticals | $19.02 | 1 |
| CapsoVision, Inc. | $15.39 | 1 |
| Phathom Pharmaceuticals, Inc. | $15.32 | 1 |
| Fresenius Kabi USA, LLC | $14.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.06 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106391232 | CMS |
| ABBVIE INC. | $18.61 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106391234 | CMS |
| ABBVIE INC. | $26.16 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106391236 | CMS |
| Ardelyx, Inc. | $26.94 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146715593 | CMS |
| Boston Scientific Corporation | $23.92 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092427609 | CMS |
| CapsoVision, Inc. | $15.39 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154308136 | CMS |
| Celgene Corporation | $21.80 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101142094 | CMS |
| Fresenius Kabi USA, LLC | $14.78 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146954586 | CMS |
| Janssen Biotech, Inc. | $34.99 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078506740 | CMS |
| Madrigal Pharmaceuticals | $19.02 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144186271 | CMS |
| Medtronic, Inc. | $37.94 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119305812 | CMS |
| Merck Sharp & Dohme LLC | $20.19 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141620996 | CMS |
| Phathom Pharmaceuticals, Inc. | $15.32 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151142659 | CMS |
| QOL Medical, LLC | $23.80 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147729416 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.